These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20545695)

  • 21. The regulation and role of osteopontin in malignant transformation and cancer.
    El-Tanani MK; Campbell FC; Kurisetty V; Jin D; McCann M; Rudland PS
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):463-74. PubMed ID: 17113338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1alpha expression through the PI3-K/Akt pathway.
    Song G; Cai QF; Mao YB; Ming YL; Bao SD; Ouyang GL
    Cancer Sci; 2008 Oct; 99(10):1901-7. PubMed ID: 19016748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation.
    Mason CK; McFarlane S; Johnston PG; Crowe P; Erwin PJ; Domostoj MM; Campbell FC; Manaviazar S; Hale KJ; El-Tanani M
    Mol Cancer Ther; 2008 Mar; 7(3):548-58. PubMed ID: 18347142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
    Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
    Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of osteopontin in cellular signaling and metastatic phenotype.
    El-Tanani MK
    Front Biosci; 2008 May; 13():4276-84. PubMed ID: 18508510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of short-hairpin RNA expression vector-mediated osteopontin RNA interference on proliferation and invasion of prostate cancer PC-3 cells].
    Liu H; Chen AM; Guo FJ; Liao H; Hu WH; Xie J
    Chin J Cancer; 2010 Jan; 29(1):43-51. PubMed ID: 20038310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteopontin silencing by small interfering RNA induces apoptosis and suppresses invasion in human renal carcinoma Caki-1 cells.
    Zhang A; Liu Y; Shen Y; Xu Y; Li X
    Med Oncol; 2010 Dec; 27(4):1179-84. PubMed ID: 19921477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation.
    Song G; Ouyang G; Mao Y; Ming Y; Bao S; Hu T
    J Cell Mol Med; 2009 Aug; 13(8B):1706-1718. PubMed ID: 19602039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
    Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
    Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
    El-Tanani MK; Jin D; Campbell FC; Johnston PG
    Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma.
    Lin J; Myers AL; Wang Z; Nancarrow DJ; Ferrer-Torres D; Handlogten A; Leverenz K; Bao J; Thomas DG; Wang TD; Orringer MB; Reddy RM; Chang AC; Beer DG; Lin L
    Oncotarget; 2015 Sep; 6(26):22239-57. PubMed ID: 26068949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer.
    Zhao B; Sun T; Meng F; Qu A; Li C; Shen H; Jin Y; Li W
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1061-70. PubMed ID: 21207061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Segment-specific targeting via RNA interference mediates down-regulation of OPN expression in hepatocellular carcinoma cells.
    Lin F; Huang CM; Cao J; Pei ZH; Gu WL; Fan SF; Li KP; Lin CM
    Genet Mol Res; 2015 Nov; 14(4):14440-7. PubMed ID: 26600502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration.
    Hayashi C; Rittling S; Hayata T; Amagasa T; Denhardt D; Ezura Y; Nakashima K; Noda M
    J Cell Biochem; 2007 Jul; 101(4):979-86. PubMed ID: 17390343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.
    Chen RX; Xia YH; Xue TC; Ye SL
    Mol Biol Rep; 2011 Aug; 38(6):3671-7. PubMed ID: 21104439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells.
    Sheng XJ; Zhou DM; Liu Q; Lou SY; Song QY; Zhou YQ
    Eur J Gynaecol Oncol; 2014; 35(3):236-42. PubMed ID: 24984534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of osteopontin short hairpin RNA on the proliferation and invasion of human renal cancer cells.
    Liu H; Chen A; Guo F; Yuan L
    J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):61-8. PubMed ID: 20155457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.